Management of Bronchiectasis with Nodules

Diagnostic Evaluation

The American Thoracic Society recommends high-resolution CT (HRCT) scanning to confirm bronchiectasis and characterize nodular patterns, which may indicate specific etiologies like NTM infection 3

The American College of Chest Physicians recommends surgical resection of a solitary pulmonary nodule due to MAC as the first-line approach, which is considered curative 1, 2
Surgery should be performed in centers with expertise in both medical and surgical management of mycobacterial diseases, as recommended by the American Thoracic Society 1

The Infectious Diseases Society of America recommends intermittent regimen: clarithromycin 1,000 mg or azithromycin 500-600 mg, ethambutol 25 mg/kg, and rifampin 600 mg three times weekly for nodular/bronchiectatic disease 4
The American Thoracic Society recommends daily regimen for more severe disease: clarithromycin 500 mg twice daily or azithromycin 250 mg daily, ethambutol 15 mg/kg/day, and rifampin 10 mg/kg/day (maximum 600 mg/day) 4

The European Respiratory Society recommends treating exacerbations with 14 days of antibiotics based on previous sputum culture results 6
The British Thoracic Society recommends considering long-term mucoactive treatment for patients with difficulty expectorating sputum, and avoiding recombinant human DNase in non-CF bronchiectasis 3, 5

The American College of Chest Physicians recommends considering surgery only in patients with adequate cardiopulmonary reserve, and surgery is not recommended for most patients with bronchiectasis except in cases of localized disease with high exacerbation frequency despite optimal medical management 1, 5
The American Thoracic Society recommends regular monitoring of sputum pathogens, especially when using long-term antibiotics, and monitoring for drug toxicity, particularly with macrolides and inhaled aminoglycosides 3